Sword Diagnostics

Sword Diagnostics is a Chicago, Illinois-based bioanalytical Contract Research Organization (CRO) dedicated to providing clients with high-quality, science-driven solutions. Employing 22 individuals, the company boasts annual revenue of $5.5 million. Sword Diagnostics prides itself on delivering projects efficiently and effectively, leveraging its team's extensive experience of over 30 years in the field. The company specializes in developing, qualifying, and validating pharmacokinetic (PK), biomarker, and immunogenicity assays. Sword Diagnostics caters to a diverse clientele, offering flexible solutions tailored to evolving needs, encompassing assay development through clinical testing in both Non-GLP and GLP environments. Sword Diagnostics differentiates itself by offering a rapid, customized, collaborative, and accessible approach to working with clients. Their commitment lies in maximizing resources and delivering timely results through open communication. Interested parties can visit Sword Diagnostics' website at swordbio.com to learn more about their services.